Medios AG (VIE:ILM1)

Market Cap	333.28M +10.7%
Revenue (ttm)	2.12B +11.0%
Net Income	13.94M -6.7%
EPS	0.56 -5.8%
Shares Out	n/a
PE Ratio	23.90
Forward PE	12.31
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	13.54
Previous Close	13.44
Day's Range	13.54 - 13.66
52-Week Range	11.28 - 17.38
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 12, 2026

About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• CEO: Thomas Meier
• Employees: 868
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: ILM1

Financial Performance

In 2025, Medios AG's revenue was 2.08 billion, an increase of 10.40% compared to the previous year's 1.88 billion. Earnings were 15.37 million, an increase of 22.45%.